ISPE Pharma 4.0™ Community of Practice (CoP) members Michelangelo Canzoneri, Hans Heesakkers, Teresa Minero, Christian Wölbeling, and Thomas Zimmer continue to explore the impact of Pharma 4.0™ on digitalization, operational excellence, and business strategy within the pharmaceutical industry in part two of this three-part series. Expanding upon part one, which onbuilding a business case for Pharma 4.0™,the CoP members reflect on the digital transformation that taken place 10 years after the start of Pharma 4.0™.
CHEManager supplies managers and executives periodically with important news, insightful interviews, substantiated market reports and technical articles related to the chemical and pharmaceutical industries.